Women's Health Guaranteed Positions

[anonymous]

I cannot believe the arrogance of some of the women health reps. One of them told me and a few others not to bother interviewing for the Ubrelvy positions because the jobs are definitely theirs. The rep was bragging that they won PC and that guaranteed them a position. This same rep was bragging last year about how easy they won because their goal was low. I talked with some others in my division and they said they heard something similar. I hope that the people who are doing the interviews dig deeper than the surface.

 

[anonymous]

All WH reps are to be let go before Q4 ends! Start looking elsewhere, the clock is ticking

 

[anonymous]

I cannot believe the arrogance of some of the women health reps. One of them told me and a few others not to bother interviewing for the Ubrelvy positions because the jobs are definitely theirs. The rep was bragging that they won PC and that guaranteed them a position. This same rep was bragging last year about how easy they won because their goal was low. I talked with some others in my division and they said they heard something similar. I hope that the people who are doing the interviews dig deeper than the surface.

Haha, I don’t believe a WH rep said that. There isn’t a single WH rep or manager that doesn’t know their place at Allergan. They are lucky they weren’t treated like the Activas reps and systematically fired or run off. The only way a WH rep would get a Ubrelvy gig is if a WH manger was hired to manage a territory AND THAT SHIT AINT HAPPENING.

 

[anonymous]

All WH reps are to be let go before Q4 ends! Start looking elsewhere, the clock is ticking

Another idiotic post. People are crawling out of the woodwork to post BS. And please let us know what will happen to loloestrin. Will it just fade away. Just because you got burned or are just a loser quit making up stuff. Go back under your rock.

 

[anonymous]

No WH reps are guaranteed a position. They will be getting severance.

 

[anonymous]

No WH reps are guaranteed a position. They will be getting severance.

And as the last poster said what will happen to loloestrin. Answer that question or is it too tough for your brain to comprehend.

 

[anonymous]

If they care so much about Lolo, why did they get rid of so many WH reps?

 

[anonymous]

And as the last poster said what will happen to loloestrin. Answer that question or is it too tough for your brain to comprehend.

You do realize Abbvie has a women's health division that can promote loloestrin?

 

[anonymous]

Are you insane? Lo Loestrin is an EXTREMELY INTENSIVE clinical sell!!! Are you aware of the difference between the white pills and the brown pills and the repercussions that could follow when considering FSH suppression, breakthrough ovulation AND the implication of THE HPO axis? How about the extended regimen sell versus the typical generic? Could you fight that battle? You need to be one of us to know what it’s like to sell, and I don’t believe you are ready for this...

 

[anonymous]

They won’t need two Women’s Health divisions. It is possible that they will keep some to sell LoLo, but not entirely certain. I am sorry that you all are going through this, because I know exactly what it feels like. My advice to you all is to just start looking to see what’s out there. And if you find something good, don’t turn it down trying to stay on to keep your severance. I see these kinds of things happen all the time. It is hard to find other pharma jobs out here that pay well. Plus, the interview process can take a while at other companies. Hope this helps.

 

[anonymous]

wtf. I would say stay on, get the one year severance then double dip or take some time off. Why would someone want to give up a years severance and just work instead?

 

[anonymous]

You do realize Abbvie has a women's health division that can promote loloestrin?

Abbvie has discussed expanding women’s health division. Orlissa has only been out about a year and not doing as well as expected. We will have a new indication coming out first half of next year for fibroids. And you think we will get LoLoestrin on top of that. Think again!

 

[anonymous]

OrMelissa sucks, no one talks about it, and big deal with the indication. Surgeries invasive or minimal will remain the standard. Lo loestrin will do laps around that drug all the way to patent expiration. Did it even do 50 million in sales this year? Our IUD makes more money than that and it’s a lower cost Me-2!

 

[anonymous]

Abbvie has discussed expanding women’s health division. Orlissa has only been out about a year and not doing as well as expected. We will have a new indication coming out first half of next year for fibroids. And you think we will get LoLoestrin on top of that. Think again!

Orilissa not doing well as expected.
UF indication coming out with comptetor Relugolix launching around the same time.
Sub-par manged care team.
Each rep averaging 60 targets per territory (where 40% or above are not accessible)
You better hope Abbvie's WH gets LoLo!

 

[anonymous]

Orilissa not doing well as expected.
UF indication coming out with comptetor Relugolix launching around the same time.
Sub-par manged care team.
Each rep averaging 60 targets per territory (where 40% or above are not accessible)
You better hope Abbvie's WH gets LoLo!

Relugolix has not submitted NDA yet so they won’t be launched at same time. Orlissa is not doing well. I hope Abbvie doesn’t lay off their own and replace them with successful LoLoestrin reps. I have heard that LoLoestrin is not the easiest product to sell. Although reps have done well with it.

 

[anonymous]

Relugolix has not submitted NDA yet so they won’t be launched at same time. Orlissa is not doing well. I hope Abbvie doesn’t lay off their own and replace them with successful LoLoestrin reps. I have heard that LoLoestrin is not the easiest product to sell. Although reps have done well with it.

Myovant Sciences intends to submit a New Drug Application of relugolix for uterine fibroids in the United States in the fourth quarter of 2019. Abbvie submitted New drug application For UF in Sept 2019

Original poster said around same time.

 

[anonymous]

wtf. I would say stay on, get the one year severance then double dip or take some time off. Why would someone want to give up a years severance and just work instead?

So, let me get this straight...IF, you were interviewing now & someone offered you a job that was paying $130K + next week, that you would stick around waiting for a severance?!! You are out of your mind!!!! Now, if the timing lines up just perfectly & you could double dip, then do so. But what I’m saying is that does not always happen.

 

[anonymous]

Abbvie has discussed expanding women’s health division. Orlissa has only been out about a year and not doing as well as expected. We will have a new indication coming out first half of next year for fibroids. And you think we will get LoLoestrin on top of that. Think again!

You would be lucky if you have a job. You best believe that Abbvie has always looked out for their people when it comes to these transitions. And LoLo is not that complicated of a sell as you make it seem. There are people over here with over 20+ years of women’s health experience!! And, Orilissa will not be sold with a BC pill. That would not be good for the indication. That’s not how that will work out. If I were you, I would start looking. It is some VERY sharp reps here!

 

[anonymous]

Orilissa not doing well as expected.
UF indication coming out with comptetor Relugolix launching around the same time.
Sub-par manged care team.
Each rep averaging 60 targets per territory (where 40% or above are not accessible)
You better hope Abbvie's WH gets LoLo!

You need to hope you keep your job and not worry about WHAT you will be selling. And most reps do have great access with the exception of some areas. Trust me, LoLo is not even a product that Abbvie is interested in. You act like it’s the holy grail of products. SMH If anything, the Botox reps/Cool Sculpting reps will keep their jobs.

 

[anonymous]

OrMelissa sucks, no one talks about it, and big deal with the indication. Surgeries invasive or minimal will remain the standard. Lo loestrin will do laps around that drug all the way to patent expiration. Did it even do 50 million in sales this year? Our IUD makes more money than that and it’s a lower cost Me-2!

Well, that depends are what territory. Some of these reps are killing it out here with Orilissa. It is a great product that takes time to get off the ground since it’s only 1 yr old. Look, what I’m saying is, you don’t need to get bogged down with numbers and who’s selling what. Just know that ABBVIE LOOKS OUT FOR THEIR OWN!!!! Most people have been here for the long haul & will continue until they retire. I have worked for other top companies in the past, but never one like Abbvie that retains soooo many reps. So, just dust off that fake resume you have in your desk drawer..